Showing results (31-40 of 39) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Communications Medicine|November 19, 2025
Peer effects on appropriate antibiotic prescribing within a patient-sharing physician network in ChinaZhiwen Gong, Mengyuan Fu, Huajie Hu, et al.JAMA Internal Medicine|October 18, 2021
Real-world Use of and Spending on New Oral Targeted Cancer Drugs in the US, 2011-2018Mengyuan Fu, Huseyin Naci, Christopher M Booth, et al.Cancers|June 19, 2020
The Deubiquitinase USP4 Stabilizes Twist1 Protein to Promote Lung Cancer Cell StemnessFengtian Li, Qingyong Hu, Tao He, et al.BMC Geriatrics|December 8, 2023
Potentially inappropriate medications among older patients with Parkinson's disease: a cross-sectional analysis of a national health insurance database in ChinaMengyuan Fu, Can Li, Zinan Zhao, et al.Oncogene|December 2, 2022
FBXL2 promotes E47 protein instability to inhibit breast cancer stemness and paclitaxel resistanceFengtian Li, Mengmeng Niu, Kewei Qin, et al.Plos Biology|February 24, 2021
Noncanonical TGF-β signaling leads to FBXO3-mediated degradation of ΔNp63α promoting breast cancer metastasis and poor clinical prognosisMengmeng Niu, Yajun He, Jing Xu, et al.Chinese Medical Journal|January 23, 2025
Prescribing rate, healthcare utilization, and expenditure of older adults using potentially inappropriate medications in China: A nationwide cross-sectional studyZinan Zhao, Mengyuan Fu, Can Li, et al.Journal of Global Health|April 11, 2024
Evaluation of pharmacist-led medication reconciliation at county hospitals in China: A multicentre, open-label, assessor-blinded, nonrandomised controlled studyMengyuan Fu, Yuezhen Zhu, Guilin Wei, et al.Nature Communications|October 12, 2021
FBXL2 counteracts Grp94 to destabilize EGFR and inhibit EGFR-driven NSCLC growthMengmeng Niu, Jing Xu, Yang Liu, et al.Pageof 4